On Feb 24, 7:17 pm, Joel <j...@[EMAIL PROTECTED]
> wrote:
> "Lizard" <lizardpri...@[EMAIL PROTECTED]
> wrote:
> >> Proof is one thing, but it's pretty clear that heavy third- and
> >> fourth-plateau users (people taking such doses more than once or
twice
> >> a week) can develop NMDA-antagonist neurotoxicity. However, it may
or
> >> may not be the largest concern - addiction itself would probably be
> >> the bigger issue to worry about.
>
> >It is not clear at all. There isn't even any convincing anecdotal
> >evidence of it. It simply does not happen, and has NEVER happened to
> >anybody, as far as can be determined by any scientific method, and
> >there have been 3 clinical studies (one in the US, one in the
> >Netherlands and one in France. I am looking for the abstracts and
> >will post them as soon as I find them) that looked for such evidence
> >and found none.
>
> It's not enough to say it hasn't been proven, and it's wrong to say
> that there isn't any convincing anecdotal evidence. Some people
> really get addicted to high-plateau DXM trips, and show signs of
> damage that would be consistent with NAN. It's not the most im****tant
> issue, I think, but it's certainly a relevant one.
>
> >Now, if what you are talking about is S*****onin Syndrome (a different
> >thing altogether) you are on firmer ground. While rare, and almost
> >always as a side effect of mixing SSRI's with very high doses of DXM,
> >it has been recorded. S*****onin Syndrome is tem****ary (if it doesn't
> >kill you, that is) and does not cause degenerative damage.
>
> I'm not sure why you considered that related to anything I said.
>
> --
> Joel Crump
It didn't. He's just one of those stoners that likes to **** with
your mind.
Ding the lizard and I'll vomit on my rug - clean it up and crash.
|
